<DOC>
	<DOC>NCT01697098</DOC>
	<brief_summary>The investigators sought to determine whether the incidence of neonatal respiratory distress syndrome (RDS) in preterm fetuses is similar with 12- vs 24-hour dosing interval of dexamethasone.</brief_summary>
	<brief_title>Dexamethasone for Preterm Labour</brief_title>
	<detailed_description>The administration of glucocorticoids to accelerate fetal lung maturity in patients with preterm delivery plays an important role for obstetrics and neonatal care. Many studies have shown that maternal administration of glucocorticoids has a significant beneficial effect in decreasing the incidence of respiratory distress syndrome (RDS) in infants delivered at 28-34 weeks of gestation.</detailed_description>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Glucocorticoids</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>All patient with threatened or established preterm labor between 28 34 weeks attended to our emergency unit emergent obstetric conditions like: Antepartum hemorrhage in severe attack Antepartum eclampsia</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Dexamethasone</keyword>
	<keyword>preterm labour</keyword>
	<keyword>respiratory distress</keyword>
</DOC>